DIECI, MARIA VITTORIA

DIECI, MARIA VITTORIA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 121 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 2008 GUARNERI, VALENTINADIECI, MARIA VITTORIACONTE, PIERFRANCO + THE ONCOLOGIST - -
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer. 2010 GUARNERI, VALENTINADIECI, MARIA VITTORIACONTE, PIERFRANCO + CANCER TREATMENT REVIEWS - -
Survival in Hormone Receptor Positive/HER2 Negative Breast Cancer Patients Treated with Preoperative Chemotherapy. 2010 DIECI, MARIA VITTORIACONTE, PIERFRANCO + CANCER RESEARCH - -
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer 2011 GUARNERI, VALENTINADIECI, MARIA VITTORIACONTE, PIERFRANCO + ANNALS OF SURGICAL ONCOLOGY - -
Timing for starting second line therapy in recurrent ovarian cancer. 2011 GUARNERI, VALENTINADIECI, MARIA VITTORIACONTE, PIERFRANCO + EXPERT REVIEW OF ANTICANCER THERAPY - -
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 2011 DIECI, MARIA VITTORIACONTE, PIERFRANCO + CANCER RESEARCH - -
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma 2012 DIECI, MARIA VITTORIACONTE, PIERFRANCO + JOURNAL OF CLINICAL ONCOLOGY - -
Tumori ginecologici 2012 CONTE, PIERFRANCOGUARNERI, VALENTINADIECI, MARIA VITTORIA + - - Oncologia Clinica Principi e Pratica
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 2012 GUARNERI, VALENTINADIECI, MARIA VITTORIACONTE, PIERFRANCO + JOURNAL OF CLINICAL ONCOLOGY - -
Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer. 2012 GUARNERI, VALENTINADIECI, MARIA VITTORIACONTE, PIERFRANCO EXPERT OPINION ON PHARMACOTHERAPY - -
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis 2012 DIECI, MARIA VITTORIACONTE, PIERFRANCOGUARNERI, VALENTINA + JOURNAL OF CLINICAL PATHOLOGY - -
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients. 2013 GUARNERI, VALENTINADIECI, MARIA VITTORIACONTE, PIERFRANCO + ANNALS OF ONCOLOGY - -
Targeting the Fibroblast Growth Factor Receptor Pathway in Human Cancer 2013 DIECI, MARIA VITTORIA + - - Targeted Therapies in Oncology
Quantification of residual risk of relapse in breast cancer patients optimally treated 2013 DIECI, MARIA VITTORIA + THE BREAST - -
The Future of Chemotherapy in the Era of Personalized Medicine 2013 DIECI, MARIA VITTORIAGUARNERI, VALENTINACONTE, PIERFRANCO CURRENT BREAST CANCER REPORTS - -
Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives 2013 DIECI, MARIA VITTORIA + CANCER DISCOVERY - -
Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer 2013 DIECI, MARIA VITTORIA + CLINICAL CANCER RESEARCH - -
New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancer 2013 DIECI, MARIA VITTORIA + CURRENT OPINION IN ONCOLOGY - -
Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers 2013 DIECI, MARIA VITTORIA + CLINICAL BREAST CANCER - -
Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies 2013 GUARNERI, VALENTINADIECI, MARIA VITTORIACONTE, PIERFRANCO DRUGS - -